144 related articles for article (PubMed ID: 5727481)
1. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
2. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
3. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
4. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
5. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
6. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
7. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
8. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
9. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
10. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
Valenta L; Lemarchand-Béraud T; Vannotti A
Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
[No Abstract] [Full Text] [Related]
11. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
12. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
13. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
Emrich D; Albani M; zur Mühlen A von
Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
[No Abstract] [Full Text] [Related]
14. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
15. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery and 131-I therapy for hyperthyroidism in the etiology of thyroid carcinoma.
Ashkar FS; Miale A; Smoak WM; Weinstein MB
South Med J; 1973 Sep; 66(9):1014-6. PubMed ID: 4733573
[No Abstract] [Full Text] [Related]
17. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
18. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
19. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
20. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
[Next] [New Search]